Literature DB >> 2174631

An autopsied case of the Crow-Fukase syndrome: a neuropathological study with emphasis on spinal roots.

F Umehara1, S Izumo, M Zyounosono, M Osame.   

Abstract

An autopsied case of the Crow-Fukase syndrome is reported. Neuropathological findings were as follows: (1) in the sural nerve, there was marked decrease of large and small myelinated fibers. Myelinated fibers showing axonal degeneration and segmental demyelination and remyelination were moderately increased. (2) In the lumbar spinal roots, myelinated fibers showing segmental demyelination and remyelination were frequently observed. The density of myelinated fibers of the ventral root was less at the dural site than the spinal site, while that of the dorsal roots was less at the spinal site than the dural site. (3) In the dorsal root ganglion, there were Nageotte's residual nodules and satelliotosis; (4) in the lumbar and thoracic spinal cord, there was pallor of the dorsal column; and (5) nerve cells showing central chromatolysis were frequently observed in the spinal anterior horn cells. Segmental demyelination and remyelination in the spinal roots and loss of myelinated fibers with axonal degeneration in the sural nerve are main neuropathological features of this syndrome.

Entities:  

Mesh:

Year:  1990        PMID: 2174631     DOI: 10.1007/BF00294621

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

1.  Frequency of nerve fiber degeneration of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. Morphometry of deep and superficial peroneal nerves.

Authors:  P J Dyck; J C Stevens; D W Mulder; R E Espinosa
Journal:  Neurology       Date:  1975-08       Impact factor: 9.910

2.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

3.  Uncompacted myelin lamellae in dysglobulinemic neuropathy.

Authors:  A Ohnishi; A Hirano
Journal:  J Neurol Sci       Date:  1981-07       Impact factor: 3.181

4.  [The pathology of the peripheral nervous system in two autopsy cases of osteosclerotic myeloma associated with polyneuropathy, skin hyperpigmentation, hypertrichosis and edema (author's transl)].

Authors:  Y Sato; A Ohnishi; J Tateishi; H Iwashita; H Shii
Journal:  Rinsho Shinkeigaku       Date:  1980-09

5.  The Crow-Fukase syndrome: a study of 102 cases in Japan.

Authors:  T Nakanishi; I Sobue; Y Toyokura; H Nishitani; Y Kuroiwa; E Satoyoshi; T Tsubaki; A Igata; Y Ozaki
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

6.  Use of SEPs to localize degeneration in a rare polyneuropathy: studies on polyneuropathy associated with pigmentation, hypertrichosis, edema, and plasma cell dyscrasia.

Authors:  H Shibasaki; A Ohnishi; Y Kuroiwa
Journal:  Ann Neurol       Date:  1982-10       Impact factor: 10.422

  6 in total
  4 in total

1.  Neurophysiological analysis of the cauda equina in POEMS syndrome.

Authors:  Hideyuki Matsumoto; Ritsuko Hanajima; Yasuo Terao; Hideji Hashida; Yoshikazu Ugawa
Journal:  Neurol Sci       Date:  2012-01-19       Impact factor: 3.307

Review 2.  Diagnosis and treatment of chronic acquired demyelinating polyneuropathies.

Authors:  Norman Latov
Journal:  Nat Rev Neurol       Date:  2014-07-01       Impact factor: 42.937

3.  Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case.

Authors:  G Sobue; M Doyu; M Watanabe; F Hayashi; T Mitsuma
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients.

Authors:  C Vital; R Gherardi; A Vital; N Kopp; J F Pellissier; M Soubrier; P Clavelou; R Bellance; M B Delisle; M M Ruchoux
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.